Hapbee (HAPB): The Netflix of Feelings
After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...
Smart for Life (SMFL) Featured by New to the Street
Interviews to Air on National Television Including Bloomberg and Fox Business
MIAMI, Oct. 14, 2022 (GLOBE NEWSWIRE) -- Smart...
Telehealth: iRhythm Technologies, Inc. (IRTC) Opening Down $43 (32%).
Let the dust settle or catch the falling knife?
Down from a peak of $270, it's been a difficult...
Hapbee Technologies (HAPB): Updates and News Archive.
Recent Headlines
UPDATED CONTINUOUSLY.
June 4, 2021: Hapbee (HAPBF) Selects Accomplished...
Video: Hapbee Testimonials.
Hapbee is powered by patented ultra-low radio frequency energy (ulRFE®) technology invented by...
Hapbee (HAPB) Expands Leadership Team to Support Aggressive Growth Strategy
VANCOUVER, BC, Aug. 6, 2021 /CNW/ - Hapbee Technologies, Inc. (TSXV: HAPB) (OTCQB: HAPBF) (FSE: HA1) ("Hapbee" or the "Company"), the leading wearable, wellness technology company has...
Aphex BioCleanse Further Expands Distribution Channels.
Aphex BioCleanse Systems Announces Partnership With Bifulco Consulting Group to Expand Distribution Channels
PITTSFORD, N.Y., May 20, 2021...
Report on Mitesco (MITI): Zacks Issues $0.53 Price Target, a 165% Potential Gain.
LIVE QUOTE
Original Report: Initiating Coverage...
BioSig (BSGM) Achieves First Commercial Sale of Three PURE EP Systems
Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence
Westport,...
It’s 2:00AM, Do You Know Where Your Fleet of $1,400 E-Bikes are Parked? DCSX
DCS (DCSX) Announces the Launch of MiEbike: a Cloud-Based Asset Tracking Solution for the Growing E-Bike Market
San...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
